{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:38:15Z","timestamp":1790959095808,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The variable clinical outcomes of mesenchymal stromal cell (MSC)-based therapy in acute respiratory distress syndrome (ARDS) are attributed to a variety of factors, including host microenvironmental factors. Interleukin-1\u03b2 (IL-1\u03b2) has been linked to the development and progression of ARDS, and we have previously found that IL-1\u03b2 could be used to predict MSC activation in vitro. However, the exact mechanisms through which IL-1\u03b2 alters the MSC function and its interaction with the host immune cells remains unknown. Therefore, the aim of this study was to assess how IL-1\u03b2 alters MSC function, with a specific focus on MSC-neutrophil interaction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Human bone marrow-derived MSCs were exposed to 20\u00a0ng\/ml IL-1\u03b2 for 1 or 24\u00a0h. Following exposure, MSCs were analyzed using bulk RNA sequencing and key secretome proteins were measured in their conditioned medium. A transwell culture system was used to evaluate the neutrophil recruitment capacity of IL-1\u03b2-exposed MSCs, with or without NF-kB inhibition. MSCs exposed to serum free medium were used as controls in all experiments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The sequencing data revealed that genes involved in response to biotic stimuli and immune response were altered in MSCs exposed to IL-1\u03b2 compared to control cells. In particular, genes essential for neutrophil recruitment were significantly upregulated after IL-1\u03b2 exposure. The functional in vitro studies further validated these results, demonstrating that MSCs exposed to IL-1\u03b2 had a significantly higher neutrophil recruitment capacity compared to unstimulated MSCs. Finally, inhibition of the NF-kB pathway resulted in a significant decrease of the MSC\u2019s capacity to recruit neutrophils to levels similar as to the unstimulated control MSCs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These data provide mechanistic insight into how inflammatory factors present in the host microenvironment might affect the interaction between MSCs and immune cells. This further highlights the need to understand the MSC mode of action, and to map out how the MSC fate might change in different host environments after administration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-026-05029-x","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T04:05:33Z","timestamp":1777003533000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["IL-1\u03b2 modulates inflammatory response of human bone marrow-derived MSCs and neutrophil recruitment in vitro via NF-kB-associated signaling"],"prefix":"10.1186","volume":"17","author":[{"given":"Nour","family":"Hassaan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zackarias","family":"S\u00f6derlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Kalafatis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa I.","family":"P\u00e5hlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Scheding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Rolandsson Enes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"5029_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41572-019-0069-0","volume":"5","author":"MA Matthay","year":"2019","unstructured":"Matthay MA, et al. Acute respiratory distress syndrome. Nat Rev Dis Primers. 2019;5:18.","journal-title":"Nat Rev Dis Primers"},{"key":"5029_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1055\/s-0039-1683996","volume":"40","author":"LA Huppert","year":"2019","unstructured":"Huppert LA, Matthay MA, Ware LB. Pathogenesis of acute respiratory distress syndrome. Semin Respir Crit Care Med. 2019;40:31\u20139.","journal-title":"Semin Respir Crit Care Med"},{"key":"5029_CR3","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/stem.2551","volume":"35","author":"MA Matthay","year":"2017","unstructured":"Matthay MA, Pati S, Lee JW. Concise review: mesenchymal stem (stromal) cells: biology and preclinical evidence for therapeutic potential for organ dysfunction following trauma or sepsis. Stem Cells. 2017;35:316\u201324.","journal-title":"Stem Cells"},{"key":"5029_CR4","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/S2213-2600(14)70217-6","volume":"2","author":"J Walter","year":"2014","unstructured":"Walter J, Ware LB, Matthay MA. Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis. Lancet Respir Med. 2014;2:1016\u201326.","journal-title":"Lancet Respir Med"},{"key":"5029_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-022-02956-3","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang J, et al. Safety, efficacy and biomarkers analysis of mesenchymal stromal cells therapy in ARDS: a systematic review and meta-analysis based on phase I and II RCTs. Stem Cell Res Ther. 2022;13:275.","journal-title":"Stem Cell Res Ther"},{"key":"5029_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-04287-4","volume":"27","author":"F Wang","year":"2023","unstructured":"Wang F, Li Y, Wang B, Li J, Peng Z. The safety and efficacy of mesenchymal stromal cells in ARDS: a meta-analysis of randomized controlled trials. Crit Care. 2023;27:31.","journal-title":"Crit Care"},{"key":"5029_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s40778-023-00231-6","volume":"10","author":"DJ Weiss","year":"2024","unstructured":"Weiss DJ, Enes SR. MSC-based cell therapy for COVID-19-associated ARDS and classical ARDS: comparative perspectives. Current Stem Cell Reports. 2024;10:9\u201319.","journal-title":"Current Stem Cell Reports"},{"key":"5029_CR8","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1093\/stcltm\/szac038","volume":"11","author":"AM Kirkham","year":"2022","unstructured":"Kirkham AM, et al. Updated living systematic review and meta-analysis of controlled trials of mesenchymal stromal cells to treat COVID-19: a framework for accelerated synthesis of trial evidence for rapid approval-FASTER approval. Stem Cells Transl Med. 2022;11:675\u201387.","journal-title":"Stem Cells Transl Med"},{"key":"5029_CR9","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jcyt.2022.10.003","volume":"25","author":"AM Kirkham","year":"2023","unstructured":"Kirkham AM, et al. Systematic review and meta-analysis of randomized controlled trials of mesenchymal stromal cells to treat coronavirus disease 2019: is it too late? Cytotherapy. 2023;25:341\u201352.","journal-title":"Cytotherapy"},{"key":"5029_CR10","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00263.2019","author":"SC Abreu","year":"2019","unstructured":"Abreu SC, et al. Lung inflammatory environments differentially alter mesenchymal stromal cell behavior. Am J Physiol Lung Cell Mol Physiol. 2019. https:\/\/doi.org\/10.1152\/ajplung.00263.2019.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"5029_CR11","doi-asserted-by":"publisher","first-page":"L908","DOI":"10.1152\/ajplung.00218.2020","volume":"319","author":"SC Abreu","year":"2020","unstructured":"Abreu SC, et al. Differential effects of the cystic fibrosis lung inflammatory environment on mesenchymal stromal cells. Am J Physiol Lung Cell Mol Physiol. 2020;319:L908\u201325.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"5029_CR12","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.04149-2020","author":"S Rolandsson Enes","year":"2021","unstructured":"Rolandsson Enes S, et al. Healthy versus inflamed lung environments differentially affect mesenchymal stromal cells. Eur Respir J. 2021. https:\/\/doi.org\/10.1183\/13993003.04149-2020.","journal-title":"Eur Respir J"},{"key":"5029_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cytogfr.2011.10.001","volume":"22","author":"G Lopez-Castejon","year":"2011","unstructured":"Lopez-Castejon G, Brough D. Understanding the mechanism of IL-1beta secretion. Cytokine Growth Factor Rev. 2011;22:189\u201395.","journal-title":"Cytokine Growth Factor Rev"},{"key":"5029_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"CADA Dobin","year":"2013","unstructured":"Dobin CADA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321.","journal-title":"Bioinformatics"},{"key":"5029_CR15","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"GDR Patro","year":"2017","unstructured":"Patro GDR, Love MI, Irizarry RA, Kingsford C. Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods. 2017;14:417\u20139.","journal-title":"Nat Methods"},{"key":"5029_CR16","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.12688\/f1000research.7563.1","volume":"4","author":"C Soneson","year":"2015","unstructured":"Soneson C, Love MI, Robinson MD. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Res. 2015;4:1521.","journal-title":"F1000Res"},{"key":"5029_CR17","doi-asserted-by":"crossref","unstructured":"W. H. Michael I Love, Simon Anders Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biology 15, (2014).","DOI":"10.1186\/s13059-014-0550-8"},{"key":"5029_CR18","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0118","author":"L-G Yu","year":"2012","unstructured":"Yu L-G, Han Y, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"OMICS"},{"key":"5029_CR19","doi-asserted-by":"crossref","unstructured":"D. E. Paul D. Thomas, Anushya Muruganujan, Tremayne Mushayahama, Laurent-Philippe Albou, Huaiyu Mi, PANTHER: Making genome-scale phylogenetics accessible to all. Protein Science 31, (2022). 34","DOI":"10.1002\/pro.4218"},{"key":"5029_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"CABM Ashburner","year":"2000","unstructured":"Ashburner CABM, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, et al. Gene Ontology: tool for the unification of biology. Nat Genet. 2000;25:25\u20139.","journal-title":"Nat Genet"},{"key":"5029_CR21","unstructured":"J. B. GO Central: Suzi A. Aleksander , Seth Carbon , J. Michael Cherry , Harold J. Drabkin , et al. The Gene Ontology knowledgebase in 2023. Genetics, (2023). 34 35"},{"key":"5029_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.795260","volume":"12","author":"S Arve-Butler","year":"2021","unstructured":"Arve-Butler S, et al. neutrophils lose the capacity to suppress T cell proliferation upon migration towards inflamed joints in juvenile idiopathic arthritis. Front Immunol. 2021;12:795260.","journal-title":"Front Immunol"},{"key":"5029_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1136\/thorax-2024-222596","volume":"80","author":"L Flower","year":"2025","unstructured":"Flower L, Vozza EG, Bryant CE, Summers C. Role of inflammasomes in acute respiratory distress syndrome. Thorax. 2025;80:255\u201363.","journal-title":"Thorax"},{"key":"5029_CR24","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/cmi.2012.40","volume":"9","author":"H Fan","year":"2012","unstructured":"Fan H, et al. Pre-treatment with IL-1beta enhances the efficacy of MSC transplantation in DSS-induced colitis. Cell Mol Immunol. 2012;9:473\u201381.","journal-title":"Cell Mol Immunol"},{"key":"5029_CR25","first-page":"24","volume":"12","author":"P Sinha","year":"2023","unstructured":"Sinha P, et al. Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials. Lancet Respir Med. 2023;12:24.","journal-title":"Lancet Respir Med"},{"key":"5029_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC. NF-kappaB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023-.","journal-title":"Signal Transduct Target Ther"},{"key":"5029_CR27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S2213-2600(18)30418-1","volume":"7","author":"MA Matthay","year":"2019","unstructured":"Matthay MA, et al. Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial. Lancet Respir Med. 2019;7:154\u201362.","journal-title":"Lancet Respir Med"},{"key":"5029_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-15-39","volume":"15","author":"G Zheng","year":"2014","unstructured":"Zheng G, et al. Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study. Respir Res. 2014;15:39.","journal-title":"Respir Res"},{"key":"5029_CR29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S2213-2600(14)70291-7","volume":"3","author":"JG Wilson","year":"2015","unstructured":"Wilson JG, et al. Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. Lancet Respir Med. 2015;3:24\u201332.","journal-title":"Lancet Respir Med"},{"key":"5029_CR30","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.jcyt.2024.03.486","volume":"26","author":"A Trivedi","year":"2024","unstructured":"Trivedi A, et al. Inter- and intra-donor variability in bone marrow-derived mesenchymal stromal cells: implications for clinical applications. Cytotherapy. 2024;26:1062\u201375.","journal-title":"Cytotherapy"},{"key":"5029_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/416036","volume":"2012","author":"J Lee","year":"2012","unstructured":"Lee J, Rhee MH, Kim E, Cho JY. BAY 11\u20137082 is a broad-spectrum inhibitor with anti-inflammatory activity against multiple targets. Mediators Inflamm. 2012;2012:416036.","journal-title":"Mediators Inflamm"},{"key":"5029_CR32","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s12015-012-9364-9","volume":"8","author":"R Carrero","year":"2012","unstructured":"Carrero R, et al. IL1beta induces mesenchymal stem cells migration and leucocyte chemotaxis through NF-kappaB. Stem Cell Rev Rep. 2012;8:905\u201316.","journal-title":"Stem Cell Rev Rep"},{"key":"5029_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2023.1204737","volume":"11","author":"M Jammes","year":"2023","unstructured":"Jammes M, Contentin R, Audigie F, Casse F, Galera P. Effect of pro-inflammatory cytokine priming and storage temperature of the mesenchymal stromal cell (MSC) secretome on equine articular chondrocytes. Front Bioeng Biotechnol. 2023;11:1204737.","journal-title":"Front Bioeng Biotechnol"},{"key":"5029_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12931-015-0316-1","volume":"17","author":"W Broekman","year":"2016","unstructured":"Broekman W, et al. TNF-alpha and IL-1beta-activated human mesenchymal stromal cells increase airway epithelial wound healing in vitro via activation of the epidermal growth factor receptor. Respir Res. 2016;17:3.","journal-title":"Respir Res"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-05029-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05029-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05029-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T10:05:24Z","timestamp":1777025124000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-026-05029-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5029"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-05029-x","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"14 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Title of the approved project: \u201cAspiration av benm\u00e4rg p\u00e5 frivilliga benm\u00e4rgsdonatorer. Studier av humana bindv\u00e4vsbildande (mesenkymala) stamceller\u201d. Name of the institutional approval committee: The Regional Ethics Review Board in Lund, Sweden. The approval number: 2009\/12. The approval date: 2009-12-17. The donors provided written informed consent. Title of the approved project: \u201cMultidisciplin\u00e4ra studier av blodbaserade biomark\u00f6rer och v\u00e4rdrespons vid inflammation, infektion och autoimmuna sjukdomar.\u201d Name of the institutional approval committee: The Regional Ethics Review Board in Lund, Sweden. The approval number: 2025-05426-01. The approval date: 2025-09-16. The donors provided written informed consent. The human bone marrow-derived MSCs (C-12974) were obtained from PromoCell (\n                      \n                      ) and Lonza (\n                      \n                      ) who has confirmed that there was an initial ethical approval for collection of human BM-hMSCs, and that the donors had signed informed consent. The human dermal microvascular endothelial cell line (HMEC-1) was obtained from ATCC (\n                      \n                      ) who has confirmed that there was an initial ethical approval for collection of the cells, and that the donors had signed informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SRE is the managing editor of Stem Cell Research and Therapy. She will have no involvement in the peer-review process or decisions on this article. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"152"}}